SEC Form D · Amendment · filed June 8, 2020
Inozyme Pharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Sarah Bhagat · Boston, MADirectorReinaldo Diaz · Boston, MADirectorRob Hopfner · Boston, MADirectorAxel Bolte · Newton, MAExec · DirectorDouglas Treco · Boston, MADirectorLynne Sullivan · Boston, MADirectorEdward Mathers · Boston, MADirectorMartin Edwards · Philadelphia, PADirectorSarah Bhagat · Boston, MADirectorLynne Sullivan · Boston, MADirectorReinaldo Diaz · Boston, MADirectorRob Hopfner · San Francisco, CADirectorEdward Mathers · Cambridge, MADirectorMartin Edwards · Philadelphia, PADirectorAxel Bolte · New York, NYExec · DirectorDouglas Treco · Marlborough, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗